Skip to main content

Table 3 Demographics of late effects (N = 37 events; N = 29 patients)

From: Outcomes of Stereotactic Body Radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules

Median time to late toxicity 192 days (range 91-483 days)
Primary v recurrent v metastatic disease N=29
Primary 11
Recurrent 12
Metastatic 6
Prescription dose N=29
45 Gy/5# 1
48 Gy/4# 5
50 Gy/1o0# 1
50 Gy/5# 9
54 Gy/3# 10
60 Gy/3# 3
Prior definitive EBRT N=29
Yes 8
No 21
Grade toxicity N=37
1 18
2 15
3 3
5 1 (one patient died of pneumonitis at d162)
Type of toxicity N=37
Chest wall pain 6
Lymphedema 1
Cough 6
Dyspnea 13
Vocal cord paralysis 1
Fatigue 2
Pneumonitis (>90 days) 5
Hemoptysis 1
Necrosis 1
Rib fracture 1
Number of courses SBRT per patient N=29
1 10
2 13
3 6
Number of sites treated per patient N=29
2 18
3 8
4 3
Number who had 2 sites treated at once/split over short period of time between 2 courses N=12